Skip to main content
SpringerLink
Log in

Evaluation of hypothalamic-pituitary function in patients with thalassemia major

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

The increased survival of patients with thalassemia major, made possible by more adequate therapeutic regimens, has emphasized the importance of the endocrine abnormalities often associated with this disease. In twelve thalassemic patients, we evaluated the hypothalamic- pituitary function by measuring plasma levels of anterior pituitary hormones under basal conditions and in the course of provocative tests. An impairment of growth hormone (GH) secretion was demonstrated in a considerable proportion (7/12) of these patients. In some of them failure of GH response to insulin-hypoglycemia and normal hormone rise after growth hormone-releasing hormone indicate a hypothalamic defect. A defective prolactin secretion was observed in the female hypogonadic but not in the male thalassemic patients. This abnormality appears to be dependent on estrogen deficiency rather than on a hypothalamic-pituitary dysfunction. In our series a high prevalence (8/12) of hypogonadism was also noticed. In these cases, the low gonadotropin levels and their unresponsiveness to gonadotropin-releasing hormone are compatible with a hypothalamic and/or pituitary damage. Lastly, the enhanced ACTH responses to the stimuli associated to a reduced Cortisol release suggest the existence, in these patients, of a diminished adrenocortical reserve. On the whole, this study has shown several derangements of the hypothalamic-pituitary function in thalassemia. This emphasizes the need for careful endocrine surveillance in this disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Masala A., Meloni T., Gallisai D., Alagna S., Rovasio P.P., Rassu S., Milia A.F. Endocrine functioning in multitransfused prepubertal patients with homozygous ß-thalassemia. J. Clin. Endocrinol. Metab. 58: 667, 1984.

    Article  CAS  PubMed  Google Scholar 

  2. Borgna-Pignatti C., De Stefano P., Zonta L., Vullo C., De Sanctis V., Meleverdi C., Naselli A., Masera G., Terzoli S., Gabutti V., Piga A. Growth and sexual maturation in thalassemia major. J. Pediatr. 106: 150, 1985.

    Article  CAS  PubMed  Google Scholar 

  3. Study group on Endocrine complications in non- endocrine diseases of the Italian Endocrine Pediatric Society (SIEDP). Prevalence of endocrine complications in patients with beta-thalassemia major. J. Endocrinol. Invest. 13 (Suppl. 3): 114, 1990 (Abstract).

    Google Scholar 

  4. Pintor C., Cella S.G., Manso P., Corda R., Dessì C., Locatelli V., Müller E.E. Impaired growth hormone (GH) response to GH-releasing hormone in thalassemia major. J. Clin. Endocrinol. Metab. 62: 263, 1986.

    Article  CAS  PubMed  Google Scholar 

  5. Leger J., Girot R., Crosnier H., Postel-Vinay M.C., Rappaport R. Normal growth hormone (GH) response to GH-releasing hormone in children with thalassemia major before puberty: a possible age-related effect. J. Clin. Endocrinol. Metab. 69: 453, 1989.

    Article  CAS  PubMed  Google Scholar 

  6. Kollmann F., Brendel L., Martinez-Saguer I., Escuriola-Ettinghausen C, Bohles H.J. Endocrinological tests in homozygous ß-thalassemia patients. J. Endocrinol. Invest. 13 (Suppl. 3): 112, 1990 (Abstract).

    Google Scholar 

  7. Shehadeh N., Hazani A., Rudolf M.C.J., Peleg I., Benderly A., Hochberg Z. Neurosecretory dysfunction of growth hormone secretion in thalassemia major. Acta Paediatr. Scand. 79: 790, 1990.

    Article  CAS  PubMed  Google Scholar 

  8. Pomarède R., Girot R., Constant S., Rappaport R. Effect du traitement hématologique sur la croissance et le développement pubertaire des enfants atteints de thalassémie majeure. Arch. Fr. Pediatr. 41: 255, 1984.

    PubMed  Google Scholar 

  9. Landau H., Gross V., Dagan I., Palti Z., Rachmilewitz E.A, Spitz I.M. Growth and sexual development before and after sex steroid therapy in patients with thalassemia major. Arch. Intern. Med. 144: 2341, 1984.

    Article  CAS  PubMed  Google Scholar 

  10. Chatterjee R., Katz M., Wonke B. Physiological induction/acceleration of puberty in patients with ß thalassemia major. In: De Sanctis V. (Ed.), Atti del Meeting Internazionale “La maturazione sessuale nella ß- talassemia major”. Accademia delle Scienze di Ferrara, 1986, p. 159.

    Google Scholar 

  11. Wang C., Tso S.C., Todd D. Hypogonadotropic hypogonadism in severe ß-thalassemia: effect of chelation and pulsatile gonadotropin- releasing hormone therapy. J. Clin. Endocrinol. Metab. 68: 511, 1989.

    Article  CAS  PubMed  Google Scholar 

  12. Costin G., Kogut M.D., Hyman C.B., Ortega J.A. Endocrine abnormalities in thalassemia major. Am. J. Dis. Child. 133: 497, 1979.

    Article  CAS  PubMed  Google Scholar 

  13. Tolis G., Politis C., Kontopoulou I., Poulatzas N., Rigas G., Saridakis C. Pituitary somatotropic and corticotropic function in patients with beta-thalassemia on iron chelation therapy. Birth Defects 23: 449, 1987.

    CAS  PubMed  Google Scholar 

  14. Greulich W.W., Pyle S.I. Radiographic atlas of skeletal development of the hand and wrist. Stanford University Press, Stanford, 1950.

    Google Scholar 

  15. Tanner J.M. Growth at adolescence. Blackwell Scientific Publications, Oxford, 1962.

    Google Scholar 

  16. Tolis G., Athanasiou V., Malachtaris S., Politis K. Growth hormone response to GRF(1–29) in males with homozygous ß-thalassemia. J. Endocrinol. Invest. 13 (Suppl. 3): 110, 1990 (Abstract).

    Google Scholar 

  17. Bozzola M., Argente J., Cisternino M., Moretta A., Valtorta A., Biscaldi I., Donnadieu M., Evain-Brion D., Severi F. Effect of human chorionic gonadotropin on growth velocity and biological growth parameters in adolescents with thalassemia major. Eur. J. Pediatr. 148: 300, 1989.

    Article  CAS  PubMed  Google Scholar 

  18. Vullo C., De Sanctis V., Katz M., Wonke B., Hoffbrand A.V., Bagni B., Torresani T., Tolis G., Masiero M., Di Palma A., Borgatti L. Endocrine abnormalities in thalassemia. Ann. N.Y. Acad. Sci. 612: 293, 1990.

    Article  CAS  PubMed  Google Scholar 

  19. Scacchi M., Danesi L., De Martin M., Dubini A., Forni L., Masala A., Gallisai D., Burrai C., Terzoli S., Boffa C., Marzano C., Cavagnini F. Treatment with biosynthetic growth hormone of short thalassaemic patients with impaired growth hormone secretion. Clin. Endocrinol. (Oxf.) 35: 335, 1991.

    Article  CAS  Google Scholar 

  20. Saenger P., Schwartz E., Markenson A.L., Graziano J.H., Levine L.S., New M.I., Hilgartner M.W. Depressed serum somatomedin activity in ß-thalassemia. J. Pediatr. 96: 214, 1980.

    Article  CAS  PubMed  Google Scholar 

  21. Herington A.C., Werther G.A., Matthews R.N., Burger H.G. Studies on the possible mechanism for deficiency of nonsuppressible insulin-like activity in thalassemia major. J. Clin. Endocrinol. Metab. 52: 393, 1981.

    Article  CAS  PubMed  Google Scholar 

  22. Giardina P.J., Gertner J.M., Grady R.W., New M.I. Improved height attainment in hypertransfused homozygous beta thalassemia on chelation therapy. J. Endocrinol. Invest. 13 (Suppl. 3): 107, 1990 (Abstract).

    Google Scholar 

  23. Vassilopoulou-Sellin R., Oyedeji C.O., Foster P.L., Thompson M.M., Saman N.A. Hemoglobin as a direct inhibitor of cartilage growth in vitro. Horm. Metabol. Res. 21: 11, 1989.

    Article  CAS  Google Scholar 

  24. De Virgiliis S., Congia M., Frau F., Argiolu F., Diana G., Cucca F., Varsi A., Sanna G., Podda G., Fodde M., Pirastu G.F., Cao A. Deferoxamine-induced growth retardation in patients with thalassemia major. J. Pediatr. 113: 661, 1988.

    Article  PubMed  Google Scholar 

  25. Postel-Vinay M.C., Gitot R., Leger J., Hocquette J.F., McKelvie P., Amar-Costesec A., Rappaport R. No evidence for a defect in growth hormone binding to liver membranes in thalassemia major. J. Clin. Endocrinol. Metab. 68: 94, 1989.

    Article  CAS  PubMed  Google Scholar 

  26. Spitz I.M., Landau H., Gross V., Trestian S., Palti Z., Rachmilewitz E. Prolactin responsiveness to TRH and metocloprami de in thalassemia. Clin. Endocrinol. (Oxf.) 16: 275, 1982.

    Article  CAS  Google Scholar 

  27. Livadas D.P., Sofroniadou K., Souvatzoglou A., Boukis M., Siafaka L, Koutras D.A. Pituitary and thyroid insufficiency in thalassemic haemosiderosis. Clin. Endocrinol. (Oxf.) 20: 435, 1984.

    Article  CAS  Google Scholar 

  28. Balducci R., Toscano V., Finocchi G., Municchi G., Mangiantini A., Boscherini B. Effect of hCG or hCG + treatments in young thalassemic patients with hypogonadotropic hypogonadism. J. Endocrinol. Invest. 13: 1, 1990.

    Article  CAS  PubMed  Google Scholar 

  29. Kletzky O.A., Costin G., Marris P.R., Bernstein G., March C.M., Mishel R.D.jr. Gonadotropin insufficiency in patients with thalassemia major. J. Clin. Endocrinol. Metab. 48: 901, 1979.

    Article  CAS  PubMed  Google Scholar 

  30. Sklar C.A., Lew L.Q., Yoon D.J, David R. Adrenal function in thalassemia major following longterm treatment with multiple transfusions and chelation therapy. Am. J. Dis. Child. 141: 327, 1987.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centro Auxologico Italiano, Milano, Italy

    L. Danesi, M. Scacchi, M. De Martin & A. Dubini

  2. Istituto di Scienze Mediche, Università di Milano, Italy

    P. Massaro, A. T. Majolo & E. E. Polli

  3. Cattedra di Endocrinologia II, Università di Milano, Centro Auxologico Italiano, Via Spagnoletto, 3, 20149, Milano, Italy

    F. Cavagnini

Authors
  1. L. Danesi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Scacchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. De Martin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Dubini
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. P. Massaro
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. T. Majolo
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. F. Cavagnini
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. E. E. Polli
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Danesi, L., Scacchi, M., De Martin, M. et al. Evaluation of hypothalamic-pituitary function in patients with thalassemia major. J Endocrinol Invest 15, 177–184 (1992). https://doi.org/10.1007/BF03348701

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03348701

Key-words

Search

Navigation